BIO国际大会
BIO International Convention BIO国际大会 http://convention.bio.org/
BIO国际大会(BIO International Convention)的举办经验。BIO以成功的商业开发、合作和投资者会议而在北美、欧洲和亚洲享有盛誉。本次会议上进行的合作，将得到BIO的一对一合作(One-on-One PartneringTM)的支持。One-on-One PartneringTM是一个可提供智能搜索、联络和安排与潜在合作伙伴和投资人单独会面的互动环境。
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Former Prime Minister of Great Britain and Northern Ireland Tony Blair, Michael J. Fox, Sir Elton John, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition - the BIO Exhibition.
FUTURE CONVENTION DATES
2012: June 18-21, Boston, MA
2013: April 22-25, Chicago, IL
2014: June 24-27, San Diego, CA
2015: June 15-18, Philadelphia, PA
2016: May 2-5, Chicago, IL
About BIO
BIO performs many services for members, but none of them are more visible than the BIO International Convention, the largest biotechnology event in the world. The BIO International Convention helps BIO fulfill its mission to help grow the global biotech industry. Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.
History and Background
The first BIO International Convention was held in 1993 and attracted approximately 1,400 attendees. The largest event to date was in Boston, Mass. in 2007, with more than 22,000 attendees. Media coverage has increased as well, from a smattering of trade-press reporters in the early years to more than 400 reporters in recent years. Many of the session topics are focused on perennial themes: raising capital in the venture and public markets; FDA, USDA, and EPA regulation; and patenting trends. Growth of the meeting, and BIO overall, has paralleled that of the young, dynamic industry BIO represents.
2011 Event Recap
The 2011 BIO International Convention wrapped up at the Walter E. Washington Convention Center in Washington, D.C. with a record number of partnering meetings, increased international attendance and participation, and panel sessions on the latest scientific, policy and business opportunities and challenges facing the biotechnology industry. The event drew 15,626 industry leaders from 48 states and 65 countries.
"The 2011 BIO International Convention was an enormous success, bringing together leaders from industry, government and academia who are working to solve some of the sector's biggest challenges," said President and CEO of BIO Jim Greenwood. "Bringing the global biotech industry to Washington, D.C. gave us the critical opportunity to showcase to key policymakers our industry's promise to offer real solutions to the most pressing global challenges such as curing disease, reducing health care costs, combating hunger, discovering alternative forms of energy and creating high-wage jobs. We continue to advocate for a policy and regulatory environment that will support innovation and inspire industry growth."
Greenwood interviewed Former Prime Minister of Great Britain and Northern Ireland Tony Blair at Tuesday's keynote. Wednesday's keynote featured U.S. Senator John Barrasso (R-WY); former U.S. Senator Tom Daschle (D-SD); Governor Howard Dean and Republican political strategist Karl Rove discussing the implementation of health care reform. The Convention program featured more than 125 breakout sessions across 15 tracks, which included Global Innovations and Markets, Health Policy and Reimbursement, Biosecurity, Business Development, Food and Agriculture, and Biofuels and Biobased Chemicals.
The top 10 largest international delegations included (in order): Canada, UK, Germany, France, Korea, Belgium, China, Japan, Spain and Australia.
The event attracted 11 U.S. Governors and more than 100 international public officials, including:
His Royal Highness Prince Philippe, Duke of Brabant, Prince of Belgium
His Excellency Steven Vanackere, Deputy Prime Minister of Belgium
The Right Honourable Tan Sri Muhyiddin Yassin, Deputy Prime Minister of Malaysia
The BIO Business Forum hosted a record breaking 21,183 partnering meetings between 2,410 companies and featured 157 company presentations. The BIO Business Forum Partnering Report indicated that there is high demand for Phase I assets as well as CNS, immunology, and metabolic therapeutic areas compared to 2010. In addition, the top three highest interest therapeutic areas in 2010 include cardiovascular, oncology and respiratory categories are now all in the bottom half of this year's top 10 areas.
The BIO Exhibition featured more than 1,800 exhibitors and covered 180,000 square feet with 61 state and international pavilions.
"The BIO International Convention is the number one event for us," said Mgr. Marek Polach of the Association of Czech Biotech Companies. "Most of the companies within the Czech Republic Pavilion are small enterprises and the U.S. is the biggest market; being at this event is critical for us to engage with the global biotech industry."
"We had a great experience at the 2011 BIO International Convention and the interactions we had this week created strong momentum for the Convention's return to Boston in 2012," said Susan R. Windham-Bannister, Ph.D., President and CEO of the Massachusetts Life Sciences Center. "Our 'road to revolution' began this week and we invite everyone to Boston to see and experience everything our region has to offer the life sciences industry."
